Advertisement

EDITORIAL COMMENT

      The authors report on 30 men treated with in-bore focal laser ablation (FLA) of clinically localized prostate cancer. This data adds to this center's previously reported 2-year early oncologic outcomes noting a 28% local recurrence rate of grade group ≥2, no metastasis or deaths.
      • Chao B
      • Llukani E
      • Lepor H
      Two-year outcomes following focal laser ablation of localized prostate cancer.
      At 5 years, the authors report 83% failure-free survival (FFS) defined by lack of salvage whole gland, systemic treatment, metastasis or prostate cancer death. In-field tumor persistence was identified in 50% of men, and 60% of these cases were managed with salvage focal ablation and one-third with whole gland therapy. Importantly, at 8 years follow-up, over 80% of men avoided whole gland therapy despite high in-field recurrence.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chao B
        • Llukani E
        • Lepor H
        Two-year outcomes following focal laser ablation of localized prostate cancer.
        Eur Urol Oncol. 2018; 1: 129-133
        • Le Nobin J
        • Rosenkrantz AB
        • Villers A
        • et al.
        Image guided focal therapy for magnetic resonance imaging visible prostate cancer: defining a 3-dimensional treatment margin based on magnetic resonance imaging histology co-registration analysis.
        J Urol. 2015; 194: 364-370
        • Priester A
        • Natarajan S
        • Khoshnoodi P
        • et al.
        Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology.
        J Urol. 2017; 197: 320-326